Muscle strength/intensive care unit acquired weakness in COVID-19 and non-COVID-19 patients

被引:12
作者
Rahiminezhad, Elham [1 ]
Zakeri, Mohammad Ali [2 ]
Dehghan, Mahlagha [3 ,4 ]
机构
[1] Kerman Univ Med Sci, Razi Fac Nursing & Midwifery, Student Res Comm, Kerman, Iran
[2] Rafsanjan Univ Med Sci, Noncommunicable Dis Res Ctr, Rafsanjan, Iran
[3] Kerman Univ Med Sci, Nursing Res Ctr, Kerman, Iran
[4] Kerman Univ Med Sci, Fac Nursing & Midwifery, Dept Crit Care, Kerman, Iran
关键词
dynamometer; intensive care unit; intensive care unit acquired weakness; muscle strength; CRITICAL ILLNESS MYOPATHY; PHYSIOTHERAPY MANAGEMENT; INVOLVEMENT; STRENGTH;
D O I
10.1111/nicc.12830
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background Intensive care unit acquired weakness (ICU-AW) affects both coronavirus disease 19 (COVID-19) and non-COVID-19 patients. ICU-AW can result in a variety of consequences, including increased patient mortality. Aims The current study aimed to compare muscle strength and ICU-AW in COVID-19 and non-COVID-19 patients. Study Design This was a cross-sectional, descriptive-analytical pilot study. Methods Fifteen conscious COVID-19 patients and 15 conscious non-COVID-19 patients admitted to the ICUs of a public hospital were selected by convenience sampling. Muscle strength in arms and legs was assessed by a hand-held dynamometer (HHD), and ICU-AW was measured with the medical research council sum score (MRC-SS) scale on the first, fourth, and seventh days of admission to ICUs. Results The results showed that muscle strength in the arms and legs of the COVID-19 patients assessed by a HHD and MRC was significantly lower than that of non-COVID-19 patients. On the fourth day of ICU admission, 80% of the COVID-19 patients and 40% of the non-COVID-19 patients had ICU-AW. All COVID-19 patients and 86.8% of the non-COVID-19 patients had ICU-AW on the seventh day of ICU admission. Conclusions Decreased muscle strength and ICU-AW are more likely in COVID-19 patients who must stay in the ICU compared with non-COVID-19 patients. Relevance to Clinical Practice Health systems should plan to provide rehabilitation facilities for COVID-19 patients and prevent prolonged complications of COVID-19.
引用
收藏
页码:1012 / 1021
页数:10
相关论文
共 50 条
  • [41] COVID-19 complicating pregnancy: A retrospective study of nine intensive care unit patients
    Sivalingam, Deepak
    Kumar, A. K. Ajith
    Shashank, M. R.
    Murthy, Pooja R.
    Gupta, K. V. Venkatesha
    OBSTETRIC MEDICINE, 2024, 17 (01) : 28 - 35
  • [42] Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19
    Mariano Duran-Manuel, Emilio
    Cruz-Cruz, Clemente
    Ibanez-Cervantes, Gabriela
    Carlos Bravata-Alcantara, Juan
    Sosa-Hernandez, Oscar
    Delgado-Balbuena, Laura
    Leon-Garcia, Gregorio
    Alejandra Cortes-Ortiz, Iliana
    Alethia Cureno-Diaz, Monica
    Castro-Escarpulli, Graciela
    Manuel Velez-Resendiz, Juan
    Manuel Bello-Lopez, Juan
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (01): : 58 - 68
  • [43] Early predictors of intensive care unit admission among COVID-19 patients in Qatar
    Abuyousef, Safae
    Alnaimi, Shaikha
    Omar, Nabil E.
    Elajez, Reem
    Elmekaty, Eman
    Abdelfattah-Arafa, Eiman
    Barazi, Raja
    Ghasoub, Rola
    Rahhal, Ala
    Hamou, Fatima
    Al-Amri, Maha
    Karawia, Ahmed
    Ajaj, Fatima
    Alkhawaja, Raja
    Kardousha, Ahmed
    Awaisu, Ahmed
    Abou-Ali, Adel
    Khatib, Mohamad
    Aboukamar, Mohammed
    Al-Hail, Moza
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [44] Predicting factors associated with prolonged intensive care unit stay of patients with COVID-19
    Han, Won Ho
    Lee, Jae Hoon
    Chun, June Young
    Choi, Young Ju
    Kim, Youseok
    Han, Mira
    Kim, Jee Hee
    ACUTE AND CRITICAL CARE, 2023, 38 (01) : 41 - 48
  • [45] Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit
    Medeiros, Sandrelli Meridiana de Fatima Ramos dos Santos
    Lino, Bruna Maria Nepomuceno Sousa
    Perez, Vinicius Pietta
    Sousa, Eduardo Sergio Soares
    Campana, Eloiza Helena
    Miyajima, Fabio
    Carvalho-Silva, Wlisses Henrique Veloso
    Dejani, Naiara Naiana
    Fernandes, Matheus Santos de Sousa
    Yagin, Fatma Hilal
    Al-Hashem, Fahaid
    Elkholi, Safaa M.
    Alyami, Hanan
    Souto, Fabricio Oliveira
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy
    Stringer, Kathleen A.
    Puskarich, Michael A.
    Kenes, Michael T.
    Dickson, Robert P.
    PHARMACOTHERAPY, 2020, 40 (05): : 382 - 386
  • [47] Preventing exposure to COVID-19 in the operation theatre and intensive care unit
    Setlur, Rangraj
    Jaiswal, Alok
    Jahan, Nikahat
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2020, 36 : S127 - +
  • [48] COVID-19 and Clostridioides difficile Coinfection Analysis in the Intensive Care Unit
    Stoian, Mircea
    Andone, Adina
    Boeriu, Alina
    Bandila, Sergio Rares
    Dobru, Daniela
    Laszlo, Sergiu Stefan
    Corau, Dragos
    Arbanasi, Emil Marian
    Russu, Eliza
    Stoian, Adina
    ANTIBIOTICS-BASEL, 2024, 13 (04):
  • [49] Determinants of Modality in Patients Admitted to Intensive Care Unit Due to COVID-19 Pneumonia
    Tosun, Mustafa
    Olmez, Hasan
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2022, 13 (01): : 12 - 17
  • [50] Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
    Klopfenstein, T.
    Zayet, S.
    Lohse, A.
    Balblanc, J-C
    Badie, J.
    Royer, P-Y
    Toko, L.
    Mezher, C.
    Kadiane-Oussou, N. J.
    Bossert, M.
    Bozgan, A-M
    Charpentier, A.
    Roux, M-F
    Contreras, R.
    Mazurier, I
    Dussert, P.
    Gendrin, V
    Conrozier, T.
    MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (05): : 397 - 400